From July 1, 2023 to September 30, 2023, the company has repurchased 4,148,600 shares, representing 0.55% for CNY 29.56 million. With this, the company has completed the repurchase of 14,148,600 shares, representing 1.84% for CNY 100.02 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 CNY | -0.30% | -2.09% | -4.93% |
1st Jan change | Capi. | |
---|---|---|
-4.93% | 654M | |
+21.43% | 44.11B | |
+23.03% | 22.71B | |
+18.22% | 15.15B | |
+12.57% | 13.56B | |
+60.18% | 12.7B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.